Maze Therapeutics, Inc. MAZE 深 沪
已收盘 08-01 16:00:00 美东时间
14.90
+0.150
+1.02%
华盛通- 最 高15.38
- 今 开14.32
- 成交量 24.33万股
- 最 低 13.82
- 昨 收 14.75
- 总市值 6.53亿
- 52周最高 19.19
- 市盈率 静 191.52
- 换手率 0.56%
- 52周最低 6.71
- 委 比 37.84%
- 总股本 4379.72万
- 历史最高 19.19
- 量 比 2.03
- 振 幅 10.58%
- 历史最低 6.71
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HC Wainwright & Co. Initiates Coverage On Maze Therapeutics with Buy Rating, Announces Price Target of $34
HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Buy rating and announces Price Target of $34.
07-23 18:26
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
Maze Therapeutics announced that its management will participate in fireside chats at two upcoming investor conferences in July: the H.C. Wainwright 4th Annual Kidney Virtual Conference on July 14, 2025, at 2:30 p.m. ET, and the BTIG Virtual Biotech Conference on July 30, 2025, at 9:20 a.m. ET. Live webcasts will be available on the company’s website, [www.mazetx.com](https://www.mazetx.com), and archived for 60 days. Maze Therapeutics is a clini...
07-10 20:05
Wedbush Initiates Coverage On Maze Therapeutics with Outperform Rating, Announces Price Target of $17
Wedbush analyst Laura Chico initiates coverage on Maze Therapeutics (NASDAQ:MAZE) with a Outperform rating and announces Price Target of $17.
07-08 20:56
Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
Maze Therapeutics, a clinical-stage biopharmaceutical company, announced that its CEO, Jason Coloma, Ph.D., will present a company overview at the Jefferies 2025 Global Healthcare Conference on June 5, 2025. A live webcast will be available on the company's website and archived for 60 days. Maze Therapeutics specializes in developing small molecule precision medicines for renal, metabolic, and cardiovascular diseases using its Compass platform, w...
05-29 11:30
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Spero Therapeutics (NASDAQ:SPRO) shares increased by 237.2% to $2.3 du...
05-28 20:08
Maze Therapeutics Q1 EPS $(1.15) Up From $(13.91) YoY
Maze Therapeutics (NASDAQ:MAZE) reported quarterly losses of $(1.15) per share. This is a 91.73 percent increase over losses of $(13.91) per share from the same period last year.
05-15 04:18
鲜艳游戏下载 十大耐玩鲜艳游戏推荐
探索游戏世界的新鲜色彩！《鲜艳游戏下载：十大耐玩鲜艳游戏推荐》带你走进一个视觉盛宴，精心挑选的亮丽游戏不仅画面炫目，更兼备深度玩法。无论是解谜、动作还是策略，每...
04-11 07:31
Maze Therapeutics GAAP EPS of -$18.32
Maze Therapeutics press release (NASDAQ:MAZE): Q4 GAAP EPS of -$18.32. Cash and cash equivalents were $196.8 million as of December 31, 2024, compared to $29.2 million as of December 31, 2023. Maze ex...
04-01 01:28
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Capstone Holding (NASDAQ:CAPS) shares increased by 107.6% to $5.19 dur...
03-17 20:11
